
Cellbyte helps pharmaceutical Pricing & Market Access teams speed drug launches by turning clinical, pricing, HTA, and regulatory data into instant answers. It offers AI-powered agents and a self-service SaaS platform that lets users query vast curated databases using natural language chat, extracting insights from documents and overcoming language barriers. The product analyzes launch sequences, performs analog searches, compares prices, explains market rationales, and runs calculations to replace manual research workflows. Cellbyte integrates a data foundation of 70+ curated sources and is built by industry and data science experts to support pharma commercial strategy at scale.

Cellbyte helps pharmaceutical Pricing & Market Access teams speed drug launches by turning clinical, pricing, HTA, and regulatory data into instant answers. It offers AI-powered agents and a self-service SaaS platform that lets users query vast curated databases using natural language chat, extracting insights from documents and overcoming language barriers. The product analyzes launch sequences, performs analog searches, compares prices, explains market rationales, and runs calculations to replace manual research workflows. Cellbyte integrates a data foundation of 70+ curated sources and is built by industry and data science experts to support pharma commercial strategy at scale.
What they do: AI platform that provides pricing, market access, regulatory and document intelligence to accelerate pharmaceutical drug launches
Product highlights: Modules include Drug Explorer, Document Intelligence, Agentic Workflows and a secure Data Vault
Target customers: Enterprise pharmaceutical Pricing & Market Access teams
Founded: 2024
Seed funding: Raised $2.75M led by Frontline Ventures; participation from Y Combinator, Pace Ventures, Saras Capital, Springboard Health Angels
Pricing, market access and regulatory intelligence for pharmaceutical drug launches
2024
Data and Analytics
2750000
Participation from Y Combinator, Pace Ventures, Saras Capital and Springboard Health Angels
“Led by Frontline Ventures with participation from Y Combinator, Pace Ventures, Saras Capital and Springboard Health Angels”